WASHINGTON (dpa-AFX) - Below are the earnings highlights for Biomarin
Pharmaceutical Inc. (BMRN):

Earnings: $20.38 million in Q4 vs. -$0.25 million in the same period last year.
EPS: $0.11 in Q4 vs. $0.00 in the same period last year.
Excluding items, Biomarin Pharmaceutical Inc. reported adjusted earnings of
$94.9 million or $0.49 per share for the period.

Analysts projected $0.23 per share
Revenue: $646.21 million in Q4 vs. $537.54 million in the same period last year.


Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX